Macrolide Antibiotics Aggravate Experimental Autoimmune Encephalomyelitis and Inhibit Inducible Nitric Oxide Synthase

REFERENCES

• Asano K., Kamakazu K., Hisamitsu T., Suzaki H. Suppressive activity of macrolide antibiotics on nitric oxide production from nasal polyp fibroblasts in vitro. Acta Otolaryngol. 2003; 123: 1064–1069
   PubMed Web of Science ®Google Scholar
• Bouwman J. J., Visseren F. L., Bevers L. M., van der Vlist W. E., Bouter K. P., Diepersloot R. J. Azithromycin reduces Chlamydia pneumoniae-induced attenuation of eNOS and cGMP production by endothelial cells. Eur. J. Clin. Invest. 2005; 35: 573–582
   PubMedGoogle Scholar
• Cao X. Y., Dong M., Shen J. Z., Wu B. B., Wu C. M., Du X. D., Wang Z., Qi Y. T., Li B. Y. Tilmicosin and tylosin have anti-inflammatory properties via modulation of COX-2 and iNOS gene expression and production of cytokines in LPS-induced macrophages and monocytes. Int. J. Antimicrob. Agents 2006; 27: 431–438
   PubMedGoogle Scholar
• Colasanti M, Suzuki H. The dual peronality of NO. Trends Pharmacol. Sci. 2000; 21: 249–252
   PubMed Web of Science ®Google Scholar
• Contini C., Cultrera R., Seraceni S., Castellazzi M., Granieri E., Fainardi E. Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing-remitting multiple sclerosis. Mult. Scler. 2004; 10: 360–369
   PubMed Web of Science ®Google Scholar
• Cowden W. B., Cullen F. A., Staykova M. A., Willenborg D. O. Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE. J. Neuroimmunol 1998; 88: 1–8
   PubMedGoogle Scholar
• Dalton D. K., Wittmer S. Nitric-oxide-dependent and independent mechanisms of protection from CNS inflammation during Th1-mediated autoimmunity: evidence from EAE in iNOS KO mice. J. Neuroimmunol. 2005; 160: 110–121
   PubMedGoogle Scholar
• Fainardi E., Castellazzi M., Seraceni S., Granieri E., Contini C. Under the microscope: Focus on Chlamydia pneumoniae infection and multiple sclerosis. Curr. Neurovasc. Res. 2008; 5: 60–70
   PubMed Web of Science ®Google Scholar
• Fenyk-Melody J. E., Garrison A. E., Brunnert S. R., Weidner J. R., Shen F., Shelton B. A., Mudgett J. S. Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J. Immunol. 1998; 160: 2940–2946
   PubMed Web of Science ®Google Scholar
• Gao X., Ray R., Xiao Y., Ray P. Suppression of inducible nitric oxide synthase expression and nitric oxide production by macrolide antibiotics in sulfur mustard-exposed airway epithelial cells. Basic Clin. Pharmacol. Toxicol. 2008; 103: 255–261
   PubMed Web of Science ®Google Scholar
• Ianaro A., Ialenti A., Maffia P., Sautebin L., Rombolà L., Carnuccio R., Iuvone T., D'Acquisto F, Di Rosa M. Anti-inflammatory activity of macrolide antibiotics. J. Pharmacol. Exp. Ther. 2000; 292: 156–163
   PubMed Web of Science ®Google Scholar
• Kahl K. G., Schmidt H. H., Jung S., Sherman P., Toyka K. V., Zielasek J. Experimental autoimmune encephalomyelitis in mice with a targeted deletion of the inducible nitric oxide synthase gene: increased T-helper 1 response. Neurosci. Lett. 2004; 358: 58–62
   PubMedGoogle Scholar
• Kahl K. G., Zielasek J., Uttenthal L. O., Rodrigo J., Toyka K. V., Schmidt H. H. Protective role of the cytokine-inducible isoform of nitric oxide synthase induction and nitrosative stress in experimental autoimmune encephalomyelitis of the DA rat. J. Neurosci. Res. 2003; 73: 198–205
   PubMedGoogle Scholar
• Khan A. A., Slifer T. R., Araujo F. G., Remington J. S. Effect of clarithromycin and azithromycin on production of cytokines by human monocytes. Int. J. Antimicrob. Agents. 1999; 11: 121–132
   PubMed Web of Science ®Google Scholar
• Lotter K., Höcherl K., Bucher M., Kees F. In vivo efficacy of telithromycin on cytokine and nitric oxide formation in lipopolysaccharide-induced acute systemic inflammation in mice. J. Antimicrob. Chemother. 2006; 58: 615–621
   PubMed Web of Science ®Google Scholar
• Mitsuyama T., Hidaka K., Furuno T., Hara N. Release of nitric oxide and expression of constitutive nitric oxide synthase of human endothelial cells: enhancement by a 14-membered ring macrolide. Mol. Cell Biochem. 1998; 181: 157–161
   PubMedGoogle Scholar
• Persichini T, Cantoni O., Suzuki H., Colasanti M. Cross-talk between constitutive and inducible NO synthase: an update. Antioxid. Redox. Signal. 2006; 8: 949–954
   PubMedGoogle Scholar
• Sahrbacher U. C., Lechner F., Eugster H. P., Frei K., Lassmann H., Fontana A. Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis. Eur. J. Immunol. 1998; 28: 1332–1338
   PubMed Web of Science ®Google Scholar
• Smith K. J., Lassmann H. The role of nitric oxide in multiple sclerosis. Lancet Neurol. 2002; 1: 232–241
   PubMed Web of Science ®Google Scholar
• Sriram S., Yao S. Y., Stratton C., Moses H., Narayana P. A., Wolinsky J. S. A pilot study to examine the effect of antibiotic therapy on MRI outcomes in relapsing remitting MS. J. Neurol. Sci. 2005; 234: 87–91
   PubMedGoogle Scholar
• Staykova M. A., Fordham S. A., Bartell G. J., Cowden W. B., Willenborg D. O. Nitric oxide contributes to the resistance of young SJL/J mice to experimental autoimmune encephalomyelitis. J. Neuroimmunol 2006; 176: 1–8
   PubMedGoogle Scholar
• Staykova M. A., Paridaen J. T., Cowden W. B., Willenborg D. O. Nitric oxide contributes to resistance of the Brown Norway rat to experimental autoimmune encephalomyelitis. Am. J. Pathol. 2005; 166: 147–157
   PubMedGoogle Scholar
• Stratton C. W., Wheldon D. B. Multiple sclerosis: an infectious syndrome involving Chlamydophila pneumoniae. Trends Microbiol 2006; 14: 474–479
   PubMedGoogle Scholar
• Tamaoki J., Kondo M., Kohri K., Aoshiba K., Tagaya E., Nagai A. Macrolide antibiotics protect against immune complex-induced lung injury in rats: role of nitric oxide from alveolar macrophages. J. Immunol. 1999; 163: 2909–2915
   PubMed Web of Science ®Google Scholar
• Teixeira S. A., Castro G. M., Papes F., Martins M. L., Rogério F., Langone F., Santos L. M., Arruda P., de Nucci G, Muscará M. N. Expression and activity of nitric oxide synthase isoforms in rat brain during the development of experimental allergic encephalomyelitis. Brain Res. Mol. Brain. Res. 2002; 99: 17–25
   PubMedGoogle Scholar
• Terao H., Asano K., Kanai K., Kyo Y., Watanabe S., Hisamitsu T., Suzaki H. Suppressive activity of macrolide antibiotics on nitric oxide production by lipopolysaccharide stimulation in mice. Mediators Inflamm. 2003; 12: 195–202
   PubMed Web of Science ®Google Scholar
• Woessner R., Grauer M. T., Frese A., Bethke F., Ginger T., Hans A., Treib J. Long-term antibiotic treatment with roxithromycin in patients with multiple sclerosis. Infection 2006; 34: 342–344
   PubMedGoogle Scholar